Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: The strong heart study

Diabetes Care

Volumn 21, Issue 8, 1998, Pages 1258-1265

  Howard, Barbara V ^a   Cowan, Linda D ^b   Go, Oscar ^b   Welty, Thomas K ^c   Robbins, David C ^a   Lee, Elisa T ^b  

^a Medlantic Research Institute   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c Aberdeen Area Indian Health Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; AMERICAN INDIAN; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RISK FACTOR; SEX DIFFERENCE;

AGED; APOLIPOPROTEINS; ARIZONA; BODY CONSTITUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES COMPLICATIONS; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; INDIANS, NORTH AMERICAN; LIPOPROTEINS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; NORTH DAKOTA; OKLAHOMA; RISK FACTORS; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 0031880796     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.8.1258     Document Type: Article

References (56)

1. Harlan WR: Cardiovascular disease care for women: service utilization, disability, and costs from the National Medical Care Utilization and Expenditure Survey. In Coronary Mean Disease in Women. Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, Eds. New York, Haymarket Doyma, 1986, p. 53-61
2. Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin-dependent diabetes. In Diabetes in America. 2nd ed. Harris MI, Cowie CC, Stem MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 47-68 (NIH Publ. no. 95-1468)
3. Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36:523-534, 1987
4. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study Diabetes Care 2:120-126, 1979
5. Kannel WB, Wilson PWF: Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 155:57-61, 1995
6. Heyden S, Heiss G, Bartel AG, Hames CG: Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chron Dis 33:265-273, 1980
7. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516, 1986
8. Elveback LR, Connolly DC, Melton LJ III: Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982. Mayo Clin Proc 61:896-900, 1986
9. DeStefano F, Ford ES, Newman J, Stevenson JM, Wetterhall SF, Anda RF, Vinicor F: Risk factors of coronary heart disease mortality among persons with diabetes, Ann Epidemiol 3:27-34, 1993
10. Sprafka JM, Pankow J, McGovern PG, French LR: Mortality among type 2 diabetic individuals and associated risk factors: the Three City Study. Diabet Med 10:627-632, 1993
11. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study JAMA 265:627-631, 1991
12. Kleinman JC Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB: Mortality among diabetics in a national sample. Am J Epidemiol 128:389-401, 1988
13. Butler WJ, Ostrander LD, Carman WJ, Lamphiear DE: Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol 121:541-547, 1985
14. Moss SE, Klein R, Klein BE: Cause-specific mortality in a population-based study of diabetes. Am J Public Health 81:1158-1162, 1991
15. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF: Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study Am J Epidemiol 135:1321-1330, 1992
16. Lee ET, Welty TK, Fabsitz R, Cowan LD, Le NA, Oopik AJ, Cucchiara AJ, Savage PJ, Howard BV: The Strong Heart Study: a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 132:1141-1155, 1990
17. Howard BV, Welty TK, Fabsitz RR, Cowan LD, Oopik AJ, Lee N-A, Yen J, Savage PJ, Lee FT: Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans: the Strong Heart Study. Diabetes 41 (Suppl. 2):4-11, 1992
18. Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK: Coronary heart disease prevalence and its relation to risk factors in American Indians: the Strong Heart Study Am J Epidemiol 142:254-268, 1995
19. Morgan C, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes 12:115-126, 1963
20. Prineas RJ, Crow RS, Blackburn H: The Minnesota Code Manual of Electrocardiographic Findings. Littleton, MA, John Wright PSC, 1982
21. Lipid Research Clinics Program: Manual of Laboratory Operations. Vol. 1. Washington, DC, Department of Health, Education, and Welfare, 1994 (DHEW Publ. no. 75-628)
22. Robbins DC, Welty TK, Wang WY, Lee ET, Howard BV: Plasma lipids and lipoprotein concentrations among American Indians: comparison with the U.S. population. Curr Opin Lipidol 7:188-195, 1996
23. INCSTAR Corporation: Antibody Reagent Set II for APO A-1 or B SPQTM Test System for The Quantitative Determination of Human Apolipoproteins by Immunoprecipitation Analysis. Stillwater, MN, INCSTAR Corporation, 1993 (Catalog no. 86059, 86060)
24. von Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17:237-246, 1957
25. Little RR, England JD, Wiedmeyer HM: Interlaboratory standardization of glycated hemoglobin determinations. Clin Chem 32:358-360, 1986
26. Vasquez B, Flock EV, Savage PJ, Nagulesparan M, Bennion LJ, Baird HR, Bennett PH: Sustained reduction of proteinuria in type 2 (non-insulin dependent) diabetes following diet-induced reduction of hyperglycemia. Diabetologia 26:127-133, 1984
27. Chasson AL, Grady HJ, Stanley MA: Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Tech 30:207-212, 1960
28. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
29. Rose GA, Blackburn H: Cardiovascular Survey Methods. 2nd ed. Geneva, World Health Org., 1982 (monogr. ser. no. 56G)
30. World Health Organization: Diabetes Mellitus: Report of a WHO Expert Committee. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
31. Welty TK, Lee ET, Yeh J, Cowan LD, Fabsitz RR, Le NA, Robbins DC, Oopik AJ, Howard BV: Cardiovascular disease risk factors among American Indians: the Strong Heart Study. Am J Epidemiol 142:269-287, 1995
32. Waaler HT: Height, weight, and mortality: the Norwegian experience. Acta Med Scand 79 (Suppl.): 1-56, 1984
33. Kissebah AH, Peiris A, Evans DJ: Mechanisms associating body fat distribution with the abnormal metabolic profiles in obesity. In Recent Advances in Obesity Research. Berry EM, Blondheim SH, Eliahou HE, Eds. London, John Libbey, 1986,p. 54-99
34. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36:54-59, 1987
35. Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F: Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography Am J Gin Nutr 44:739-746, 1986
36. Sparrow D, Borkan GA, Gerzof SG, Wisniewski C, Silbert CK: Relationship of fat distribution to glucose tolerance: results of computed tomography in male participants of the Normative Aging Study Diabetes 35:411-415, 1986
37. Seidell JC, Björntorp P, Sjöström L: Abdominal obesity and metabolism in men: possible role of behavioural characteristics. In Obesity in Europe: Proceedings of the First European Congress on Obesity. Björntorp P, Rössner S, Eds. London, John Libbey, 1989, p. 91-99
38. Larsson B, Bengtsson C, Björntorp P, Lapidus L, Sjöström L, Kvärdsudd K, Tibblin G, Wedel H, Welin L, Wilhelmsen L: Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol 135:266-273, 1992
39. Larsson B: Regional obesity as a health hazard in men: prospective studies. Acta Med Scand 549 (Suppl.): 106-121, 1973
40. Lapidus L, Bengtsson C: Regional obesity as a health hazard in women: a prospective study. Acta Med Scand 723 (Suppl.):53-59, 1988
41. Barrett-Connor E, Grundy SM, Holdbrook JJ: Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 115:657-663, 1982
42. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 120:834-851, 1984
43. Assman G, Schulte H: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary heart disease (the PROCAM experience). Am J Cardiol 70:733-737, 1992
44. Cowie CC, Howard BV, Harris MI: Serum lipoproteins in African Americans and whites with non-insulin dependent diabetes in the US population. Circulation 90:1185-1193, 1994
45. Orchard TJ: Dyslipoproteinemia and diabetes. Endocrinol Metab Clin North Am 19:361-380, 1991
46. Evans RW, Orchard TJ: Oxidized lipids in insulin-dependent diabetes mellitus: a sex-diabetes interaction? Metabolism 43:1196-1200, 1994
47. Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Bennett PH: Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population: comparison of diabetics and nondiabetics. Arteriosclerosis 4:462-471, 1984
48. Howard BV, Abbott WGH, Egusa G, Taskinen M-R: Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects of obesity and non-insulin-dependent diabetes mellitus (Abstract). Am Heart Assn J 113:522, 1987
49. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 59:8-13, 1979
50. Carmassi F, Morale M, Puccetti R, De Negri F, Monzani F, Navalesi R, Mariani G: Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thrombosis Res 67:643-654, 1992
51. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
52. Kannel WB, Wilson PW: Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 155:57-61, 1995
53. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR: Menopause and risk factors for coronary heart disease. N Engl J Med 321:641-646, 1989
54. Wahl PW, Walden CE, Knopp RH, Warnick GR, Hoover JJ, Hazzard WR, Albers JJ: Lipid and lipoprotein triglyceride and cholesterol interrelationships: effects of sex, hormone use, and hyperlipidemia. Metabolism 33:502-508, 1984
55. Knopp RH, Zhu X, Bonet B: Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis 110 (Suppl.):S83-S91, 1995
56. Peiris AN, Aiman EJ, Drucker WD, Kissebah AH: The relative contributions of hepatic and peripheral tissue to insulin resistance in hyperandrogenic women. J Clin Endocrin Metab 68:715-720, 1989